These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2796400)

  • 1. Nerve glucose, sorbitol, fructose, and myo-inositol at various time after feeding in streptozotocin-induced diabetes in rats.
    Dyck PJ; Minnerath SR; O'Brien PC
    Mayo Clin Proc; 1989 Aug; 64(8):905-10. PubMed ID: 2796400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
    Whiting PH; Ross IS
    Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-lipoic acid: effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy.
    Kishi Y; Schmelzer JD; Yao JK; Zollman PJ; Nickander KK; Tritschler HJ; Low PA
    Diabetes; 1999 Oct; 48(10):2045-51. PubMed ID: 10512372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats.
    Gillon KR; Hawthorne JN
    Biochem J; 1983 Mar; 210(3):775-81. PubMed ID: 6870806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyol pathway activity and myo-inositol metabolism. A suggested relationship in the pathogenesis of diabetic neuropathy.
    Finegold D; Lattimer SA; Nolle S; Bernstein M; Greene DA
    Diabetes; 1983 Nov; 32(11):988-92. PubMed ID: 6416910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in sorbitol, myo-inositol and lipid inositol in dorsal root and sympathetic ganglia from streptozotocin-diabetic rats.
    Llewelyn JG; Simpson CM; Thomas PK; King RH; Hawthorne JN
    Diabetologia; 1986 Dec; 29(12):876-81. PubMed ID: 3569691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in cardiac muscle fructose content in streptozotocin-induced diabetic rats.
    Kashiwagi A; Obata T; Suzaki M; Takagi Y; Kida Y; Ogawa T; Tanaka Y; Asahina T; Ikebuchi M; Saeki Y
    Metabolism; 1992 Oct; 41(10):1041-6. PubMed ID: 1406291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
    Tomlinson DR; Mayer JH
    Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor nerve conduction velocity and nerve polyols in mice with short-term genetic or streptozotocin-induced diabetes.
    Whiteley SJ; Tomlinson DR
    Exp Neurol; 1985 Aug; 89(2):314-21. PubMed ID: 3160601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats.
    Wright RA; Nukada H
    Brain; 1994 Dec; 117 ( Pt 6)():1395-407. PubMed ID: 7820575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes.
    Knudsen GM; Jakobsen J; Barry DI; Compton AM; Tomlinson DR
    Neuroscience; 1989; 29(3):773-7. PubMed ID: 2525678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes and the myo-inositol paradox.
    Loy A; Lurie KG; Ghosh A; Wilson JM; MacGregor LC; Matschinsky FM
    Diabetes; 1990 Oct; 39(10):1305-12. PubMed ID: 2210080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
    Tomlinson DR; Sidenius P; Larsen JR
    Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes.
    Gabbay KH; Merola LO; Field RA
    Science; 1966 Jan; 151(3707):209-10. PubMed ID: 5907911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylcobalamin improves nerve conduction in streptozotocin-diabetic rats without affecting sorbitol and myo-inositol contents of sciatic nerve.
    Sonobe M; Yasuda H; Hatanaka I; Terada M; Yamashita M; Kikkawa R; Shigeta Y
    Horm Metab Res; 1988 Nov; 20(11):717-8. PubMed ID: 3215630
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal sorbitol, myo-inositol and glycerophosphorylcholine in streptozotocin-diabetic rats.
    Schmolke M; Schleicher E; Guder WG
    Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):607-14. PubMed ID: 1493153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sorbitol, inositol and nerve conduction in diabetes.
    Gillon KR; Hawthorne JN
    Life Sci; 1983 Apr; 32(17):1943-7. PubMed ID: 6835015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.